| 标题 |
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC |
| 网址 | |
| DOI | |
| 其它 |
期刊:Digestive and Liver Disease 作者:D. Gabbia; I. Zanotto; Y. Frion-Herrera; A. De Rossi; A. Grigoletto; et al 出版日期:2023-09-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)